Structure of a biologically active estrogen receptor-coactivator complex on DNA.

Molecular Cell
Ping YiB W O'Malley

Abstract

Estrogen receptor (ER/ESR1) is a transcription factor critical for development, reproduction, metabolism, and cancer. ER function hinges on its ability to recruit primary and secondary coactivators, yet structural information on the full-length receptor-coactivator complex to complement preexisting and sometimes controversial biochemical information is lacking. Here, we use cryoelectron microscopy (cryo-EM) to determine the quaternary structure of an active complex of DNA-bound ERα, steroid receptor coactivator 3 (SRC-3/NCOA3), and a secondary coactivator (p300/EP300). Our structural model suggests the following assembly mechanism for the complex: each of the two ligand-bound ERα monomers independently recruits one SRC-3 protein via the transactivation domain of ERα; the two SRC-3s in turn bind to different regions of one p300 protein through multiple contacts. We also present structural evidence for the location of activation function 1 (AF-1) in a full-length nuclear receptor, which supports a role for AF-1 in SRC-3 recruitment.

References

May 1, 1988·Quarterly Reviews of Biophysics·J DubochetP Schultz
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·B HansteinM Brown
Oct 24, 1997·Nature·A M BrzozowskiM Carlquist
Apr 6, 2001·Cellular and Molecular Life Sciences : CMLS·J W LeeS K Lee
May 22, 2001·Molecular and Cellular Biology·E T ManningW L Kraus
Sep 19, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tamaki SuganumaMasa-Aki Ikeda
Aug 2, 2003·Molecular Endocrinology·Anette WärnmarkJan-Ake Gustafsson
Jul 17, 2004·Genes & Development·Hua ZhangYongfeng Shang
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wenlin ShaoMyles Brown
Mar 17, 2006·The Journal of Biological Chemistry·Lorna WatersDavid M Heery
Jul 25, 2006·Journal of Structural Biology·Guang TangSteven J Ludtke
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Irina I SeryshevaWah Chiu
Dec 2, 2008·Nature·Vikas ChandraFraydoon Rastinejad
Feb 26, 2010·Molecular Endocrinology·Rainer B LanzBert W O'Malley
Mar 12, 2010·Genome Research·Dominic SchmidtDuncan T Odom
Sep 24, 2011·Journal of Molecular Biology·Richard HendersonPeter B Rosenthal
Feb 14, 2012·Structure·Richard HendersonCatherine L Lawson
Feb 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Judit OszDino Moras
Jul 31, 2012·Nature Methods·Sjors H W Scheres, Shaoxia Chen
Sep 25, 2012·Journal of Structural Biology·Sjors H W Scheres
Mar 15, 2013·Nature·Vikas ChandraFraydoon Rastinejad
May 28, 2013·Structure·Stephen C MurrayIrina I Serysheva
Nov 10, 2013·Journal of Molecular Endocrinology·Christopher J MillardJohn W R Schwabe

❮ Previous
Next ❯

Citations

Nov 19, 2015·Nucleic Acids Research·Catherine L LawsonWah Chiu
Jan 31, 2016·Journal of Molecular Endocrinology·Sylvia C HewittKenneth S Korach
Sep 24, 2015·Wiley Interdisciplinary Reviews. RNA·Andrew P Rice
May 20, 2016·IUBMB Life·Valeria PesiriFilippo Acconcia
Feb 26, 2016·The Journal of Endocrinology·Koen D Flach, Wilbert Zwart
Jul 7, 2016·Journal of Molecular Biology·Sandra L GrimmDean P Edwards
Feb 7, 2017·Nature Communications·Marta NadalEva Estébanez-Perpiñá
Jun 1, 2016·Chemical Society Reviews·Peter Tompa
Mar 1, 2018·Proceedings of the National Academy of Sciences of the United States of America·David Cotnoir-WhiteSylvie Mader
Jun 15, 2017·Molecular & Cellular Proteomics : MCP·Joanna K LempiäinenJorma J Palvimo
Jun 15, 2018·Endocrine Reviews·Sylvia C Hewitt, Kenneth S Korach
May 11, 2016·Molecular Endocrinology·Gaëlle PalierneRaphaël Métivier
Apr 24, 2016·Molecular Systems Biology·Jerome C NwachukwuKendall W Nettles
Jun 9, 2015·Endocrine Reviews·Päivi PihlajamaaOlli A Jänne
Jul 16, 2020·International Journal of Molecular Sciences·Amela Jusic On Behalf Of The Eu-CardioRNA Cost Action
Sep 30, 2020·Nucleic Acids Research·Anna Y BelorusovaNatacha Rochel
Apr 19, 2020·Nature Reviews. Endocrinology·Karolien De BosscherLuc Brunsveld
Dec 9, 2016·Breast Cancer Research : BCR·Elodie ChantalatFrançoise Lenfant
Aug 16, 2018·Protein Science : a Publication of the Protein Society·Emily R WeikumEric A Ortlund
Feb 9, 2017·Cellular and Molecular Life Sciences : CMLS·Frank ClaessensChristine Helsen
Jun 15, 2017·Cellular and Molecular Life Sciences : CMLS·Kris PauwelsPeter Tompa
Dec 21, 2017·Reproductive Medicine and Biology·Pelin YaşarMesut Muyan
Mar 27, 2019·NPJ Precision Oncology·Humberto De VittoZigang Dong
May 26, 2017·Physiological Reviews·Jean-Francois ArnalJohn Katzenellenbogen
Nov 13, 2018·The Journal of Clinical Investigation·Yoshikazu JohmuraMakoto Nakanishi
Oct 13, 2017·Nature Communications·Vikas ChandraFraydoon Rastinejad
Jun 15, 2017·Cancer Research·Aarti D RohiraBert W O'Malley
Jan 21, 2018·Cancer Research·Katarzyna A LudwikDeborah A Lannigan
May 10, 2020·Molecular Cancer Therapeutics·Kaitlyn J AndreanoDonald P McDonnell
Jan 20, 2021·Nature Medicine·Theresa E HickeyWayne D Tilley
Jan 30, 2021·The Biochemical Journal·Martin StortzValeria Levi
Jan 2, 2021·The Journal of Biological Chemistry·Irfan AsanganiTrevor M Penning

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.